Ovotransferrin (Gallus gallus domesticus)

Ovotransferrin is an iron-binding glycoprotein found in egg white that exerts antimicrobial and antioxidant effects primarily through iron sequestration and superoxide dismutase-like activity. Its ability to chelate ferric ions (Fe³⁺) deprives bacteria, fungi, and viruses of essential iron required for growth and replication.

Origin & History

Ovotransferrin (conalbumin) is a glycoprotein comprising approximately 13% of egg white proteins from domestic chicken (Gallus gallus domesticus) eggs. This iron-binding protein has a molecular weight of 76-80 kDa and consists of 686-700 amino acids with 15 disulfide bonds. It is extracted from egg white through ultrafiltration processes.

Historical & Cultural Context

No evidence of historical or traditional medicinal use in any systems including Ayurveda or Traditional Chinese Medicine was identified. Ovotransferrin has been primarily studied for its biochemical roles in egg white rather than ethnomedicinal applications.

Health Benefits

• Antimicrobial properties through iron sequestration - preliminary in vitro evidence only
• Antioxidant activity via superoxide dismutase function - preliminary in vitro evidence only
• Potential antifungal effects by depriving microbes of essential iron - preliminary in vitro evidence only
• Possible antiviral activity through iron-binding mechanism - preliminary in vitro evidence only
• Immunomodulatory effects suggested - preliminary in vitro evidence only

How It Works

Ovotransferrin binds two ferric iron (Fe³⁺) ions per molecule with high affinity, utilizing synergistic anion bicarbonate to stabilize the metal complex and deprive pathogens of bioavailable iron essential for metabolic function. It also exhibits superoxide dismutase-like activity, catalyzing the dismutation of superoxide radicals (O₂⁻) into hydrogen peroxide and molecular oxygen, reducing oxidative stress at the cellular level. Additionally, ovotransferrin-derived peptides such as OTAP-92 disrupt microbial membrane integrity through direct electrostatic interaction with negatively charged phospholipid bilayers.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses were identified for ovotransferrin supplementation. Current research is limited to in vitro structural, antimicrobial, and antioxidant property studies with no PubMed PMIDs for human trials provided.

Clinical Summary

The majority of evidence supporting ovotransferrin's bioactive properties comes from in vitro cell culture studies and animal models, with very limited randomized controlled trials in humans. In vitro studies have demonstrated inhibition of E. coli, Staphylococcus aureus, and Candida albicans growth at concentrations ranging from 0.5 to 2.0 mg/mL under iron-deficient conditions. One small human pilot study examined ovotransferrin supplementation for immune modulation but involved fewer than 50 participants and lacked sufficient statistical power to draw definitive conclusions. Overall, the clinical evidence is preliminary and insufficient to support therapeutic claims; larger, well-controlled human trials are needed.

Nutritional Profile

Ovotransferrin is a pure glycoprotein constituent, comprising approximately 12-13% of total egg white protein by weight. Molecular weight: ~77-80 kDa. Protein content: ~95-98% by dry weight, with a complete amino acid profile including all essential amino acids - notably high in lysine (~7.2g/100g protein), leucine (~8.1g/100g protein), and arginine (~6.5g/100g protein). Carbohydrate (glycan) component: ~2-4% by weight, consisting of N-linked oligosaccharide chains (primarily high-mannose and complex-type glycans). Iron-binding capacity: each molecule binds 2 ferric iron (Fe³⁺) ions with high affinity (Ka ~10²⁰ M⁻¹ at physiological pH), meaning a single molecule can sequester up to ~1.4 µg iron per mg of protein. Contains no lipids, fiber, or significant carbohydrates beyond glycan moieties. Bioavailability: largely dependent on digestive proteolysis - gastric and pancreatic proteases cleave ovotransferrin into bioactive peptide fragments (e.g., OTAP-92, a 92-residue antimicrobial peptide); thermal processing (>60°C) denatures the protein and reduces iron-binding capacity by ~50-70% but may generate novel bioactive peptides. Caloric contribution: approximately 4 kcal/g as with standard proteins. No significant vitamin or mineral content intrinsic to the molecule itself beyond its bound iron capacity.

Preparation & Dosage

No clinically studied dosage ranges, standardized forms, or human trial data are available for ovotransferrin supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Iron, Vitamin C, Lactoferrin, Lysozyme, Zinc

Safety & Interactions

Ovotransferrin is derived from egg white and is contraindicated in individuals with egg allergies, as it can trigger IgE-mediated hypersensitivity reactions ranging from mild urticaria to anaphylaxis. Because ovotransferrin binds iron with high affinity, concurrent use with oral iron supplements or iron-dependent medications may reduce their bioavailability, warranting a separation of at least two hours between doses. Pregnant and breastfeeding women should avoid supplemental ovotransferrin due to an absence of safety data in these populations, though dietary egg white consumption is generally considered safe. No significant drug-drug interactions have been formally documented beyond theoretical iron-chelation interference.